Literature DB >> 11913499

Risk factors for penicillin resistance and mortality in Korean adults with Streptococcus pneumoniae bacteremia.

B N Kim1, L G Bae, M N Kim, S J Park, J H Woo, J Ryu, Y S Kim.   

Abstract

A retrospective analysis was performed to measure the incidence of pneumococcal bacteremia and to identify risk factors for penicillin resistance and prognostic factors for outcome in adults. A total of 151 cases of pneumococcal bacteremia were identified from 149 adults during the period 1996-2000. The overall rate of penicillin resistance was 49%, ranging from 54.2% in 1996 to 48.5% in 2000 (P=0.93). Rates of resistance to ceftriaxone, clindamycin, erythromycin, and trimethoprim-sulfamethoxazole were 21.6%, 51%, 62%, and 44.7%, respectively. Multidrug resistance was documented in 47.7% of the cases. Penicillin resistance was significantly associated with solid tumor, biliary drainage catheter, and previous beta-lactam therapy in the univariate analysis. However, the associations were not as significant as independent risk factors in the multivariate analysis. Mortality was 23.8% and did not change significantly during the study period (P=0.06). Mortality rates in cases caused by penicillin-susceptible Streptococcus pneumoniae and penicillin-resistant Streptococcus pneumoniae were 23% and 24.7%, respectively (P=0.81). Mortality was not significantly influenced by penicillin resistance, even high-level resistance (24.4% vs. 20%; P=0.64). Multivariate analysis revealed that antineoplastic chemotherapy, respiratory failure, and acute renal failure were independent prognostic factors for mortality. In conclusion, the rate of penicillin resistance among pneumococcal blood isolates was high in the late 1990s, but penicillin resistance, and even high-level penicillin resistance, was not significantly associated with increased mortality in adults with pneumococcal bacteremia.

Entities:  

Mesh:

Year:  2002        PMID: 11913499     DOI: 10.1007/s10096-001-0650-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  4 in total

1.  Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics.

Authors:  Pierre Abgueguen; Esther Azoulay-Dupuis; Violaine Noel; Pierre Moine; Veronique Rieux; Bruno Fantin; Jean-Pierre Bedos
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

2.  Vancomycin-tolerant Streptococcus pneumoniae in Korea.

Authors:  Heungsup Sung; Hee Bong Shin; Mi-Na Kim; Kyungwon Lee; Eui-Chong Kim; Wonkeun Song; Seok Hoon Jeong; Wee-Gyo Lee; Yeon-Joon Park; George M Eliopoulos
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

3.  Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study.

Authors:  S E Beekmann; D J Diekema; K P Heilmann; S S Richter; G V Doern
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-05       Impact factor: 3.267

4.  A 2011-2012 survey of doctors' perceptions of korean guidelines and empirical treatment of community-acquired pneumonia.

Authors:  Hye-In Kim; Shin-Woo Kim; Hyun-Ha Chang; Jong-Myung Lee; Kyong Ran Peck
Journal:  Infect Chemother       Date:  2013-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.